KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Crescent Capital BDC (CCAP) over the last 5 years, with Q3 2025 value amounting to $2.3 million.

  • Crescent Capital BDC's Other Non-Current Liabilities rose 284935.06% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 284935.06%. This contributed to the annual value of $84000.0 for FY2023, which is 4649.68% down from last year.
  • Latest data reveals that Crescent Capital BDC reported Other Non-Current Liabilities of $2.3 million as of Q3 2025, which was up 284935.06% from $2.6 million recorded in Q2 2025.
  • Over the past 5 years, Crescent Capital BDC's Other Non-Current Liabilities peaked at $2.6 million during Q2 2025, and registered a low of $25000.0 during Q3 2022.
  • Over the past 5 years, Crescent Capital BDC's median Other Non-Current Liabilities value was $157000.0 (recorded in 2022), while the average stood at $521461.5.
  • Per our database at Business Quant, Crescent Capital BDC's Other Non-Current Liabilities tumbled by 8645.16% in 2024 and then surged by 610476.19% in 2025.
  • Crescent Capital BDC's Other Non-Current Liabilities (Quarter) stood at $631000.0 in 2021, then plummeted by 75.12% to $157000.0 in 2022, then crashed by 46.5% to $84000.0 in 2023, then fell by 8.33% to $77000.0 in 2024, then soared by 2849.35% to $2.3 million in 2025.
  • Its Other Non-Current Liabilities stands at $2.3 million for Q3 2025, versus $2.6 million for Q2 2025 and $284000.0 for Q1 2025.